Minnesota’s psychedelic medicine taskforce published their first major report on Wednesday, including their recommendations on the use of psychedelic drugs like psylocibin, MDMA and LSD for medical purposes.

The taskforce has tapped into a growing body of research that suggests that these psychedelic drugs could be a game changer in the field of psychotherapy to treat conditions like addiction, PTSD, depression and bipolar disorder.

Jessica Nielson, a neuroscientist and the chair of the Psychedelic Medicine Taskforce, joined Minnesota Now host Nina Moini to explain the taskforce’s recommendations.